| 000 | 00749nam a2200253Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220928115653.0 | ||
| 006 | a|||||r|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 220927b |||||||| |||| 00| 0 eng d | ||
| 024 | _a93397 | ||
| 037 | _cTextual | ||
| 040 |
_aSDCL _cSDCL _beng |
||
| 041 |
_2eng _aeng |
||
| 082 | _aE9G,9823: f3, P9 | ||
| 100 |
_aBrien Tom O Ed. _9445431 |
||
| 245 | 0 | _aDesign of caspase inhibitors as potential clinical agents. | |
| 260 |
_aLondon _bCRC Press _c2009 |
||
| 300 |
_axi,299p _ccm. |
||
| 490 | _aCRC enzyme inhibitors series. | ||
| 700 |
_a Linton Steven D Ed. _9445432 |
||
| 942 |
_hE9G,9823: f3, P9 _cTEXL _2CC |
||
| 999 |
_c760377 _d760377 |
||